there is a new trial about to begin .. its a phase 2 trial that could be a pivotal trial.. trastuzumab-dm1..
http://www.clinicaltrials.gov/ct2/results?term=dm1
the link says not recruiting yet.. but you would qualify based on tykerb /xeloda dosing history...
you should look into this asap
run to live